Add BrightSurf on Google Email

Flavor restrictions affect tobacco buyers differently depending on socioeconomic status, researchers say

Researchers found that restricting menthol flavor in cigarettes while making nicotine replacement therapy more available can decrease socioeconomic disparities in tobacco use. The study used an online platform to simulate the effects of policy changes on purchase behavior, showing that policies must consider interplay to be effective.

SourceVirginia Tech·JournalNicotine & Tobacco Research·TypeData/statistical analysis·DateJun 6, 2024

Affordable Care Act expansions improved access to cancer care, study suggests

A study published by University of Pittsburgh researchers found that ACA insurance expansions led to an increase in patients receiving care at accredited cancer hospitals in Pennsylvania. The study suggests that these expansions make a difference in improving access to high-quality cancer care, particularly for those living in areas wi...

SourceUniversity of Pittsburgh·JournalHealth Services Research·TypeData/statistical analysis·DateMay 3, 2024

Many hookah manufacturers have not complied with FDA-mandated nicotine warning labels

A recent study found that only half of hookah packages included the required nicotine warnings, two years after federal regulation was implemented. The study led by Boston University School of Public Health researcher Dr. Jennifer Ross highlights the importance of warning labels in communicating health risks to consumers.

SourceBoston University School of Public Health·JournalJAMA Network Open·TypeObservational study·DateFeb 7, 2024

Preapproval requirement for oral anticancer drugs may interfere with treatment

A new study from Harvard Medical School researchers found that prior authorizations for oral cancer drugs can lead to significant delays in patients' obtaining the medication, increasing the likelihood of discontinuation. The analysis of Medicare Part D claims data revealed an average delay of 10 days in refilling prescriptions after a...

SourceHarvard Medical School·JournalJournal of Clinical Oncology·TypeData/statistical analysis·DateDec 12, 2023

Real world data shows impact of immunotherapy in populations underrepresented in clinical trials, according to JNCCN study

A recent study published in JNCCN found that patients from underrepresented groups treated with first-line immunotherapy for advanced Non-Small Cell Lung Cancer (NSCLC) showed similar survival outcomes as their White counterparts. The study analyzed data from 248 patients and highlighted the need for more diverse patient representation...

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateDec 11, 2023

Most non-English speakers in the U.S. are turned away before their first cancer visit according to new research in JNCCN

A new study from the University of Michigan found significant language-based disparities in patients' access to cancer care. English-speaking callers were able to get information on next steps 94% of the time, while Spanish-speakers and Mandarin-speakers were only connected at 38% and 28% respectively.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateSep 6, 2023

New ‘promising medicines’ fund may incentivise commercialisation of high price drugs with weak evidence on clinical benefits

A new fund to fast-track patient access to potentially valuable new medicines may incentivise the pharmaceutical industry to develop high-priced drugs for rare diseases with weak clinical evidence. The NHS England Innovative Medicines Fund risks disincentivising the generation of essential evidence if not implemented appropriately.

SourceSAGE·JournalJournal of the Royal Society of Medicine·TypeObservational study·DateAug 24, 2023

Policy to expand Medicaid coverage linked to higher participation in cancer clinical trials among people insured by Medicaid

Researchers found a 19% annual increase in Medicaid-insured cancer patients participating in publicly funded clinical trials after the Affordable Care Act Medicaid expansion. The study shows that targeted policies can increase access to health care and cancer clinical trials for those with Medicaid insurance.

SourceFred Hutchinson Cancer Center·JournalJAMA Oncology·TypeData/statistical analysis·DateAug 17, 2023

Policies favoring high-volume hospitals may disadvantage rural cancer patients

Patients with cancer who live in rural Pennsylvania counties are more likely to receive complex surgeries at high-volume hospitals due to their perceived better outcomes. However, for less complex surgeries, rural patients are less likely to opt for high-volume hospitals despite potential benefits from centralization.

SourceUniversity of Pittsburgh·JournalJCO Oncology Practice·TypeComputational simulation/modeling·DateAug 17, 2023

The Endocrine community joins forces on European Hormone Day to raise awareness of vital role of hormones in preventing and treating rare and chronic diseases

The European Society of Endocrinology, ESE Foundation, and other partners mark the second European Hormone Day to promote better understanding of hormone roles and encourage change in health policy. The 'Milano Declaration' calls for stronger inclusion of endocrine health perspective in European policies.

Study: More paid sick leave results in more cancer screenings

A Tulane University study found that areas with paid sick leave mandates experienced significant increases in breast cancer (4%) and colorectal cancer (6-8%) screenings among private sector employees. The findings suggest that non-monetary barriers to healthcare access can have a meaningful impact on health outcomes.

SourceTulane University·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateMar 1, 2023

The price of cancer

The study estimates the global economic cost of cancers to fall around $25.2 trillion in international dollars by 2050, accounting for 0.55% of global GDP. Lung cancer is identified as the type with the highest economic burden, followed by colon and rectum cancer, breast cancer, liver cancer, and leukemia.

SourceInternational Institute for Applied Systems Analysis·JournalJournal of the American Medical Association·DateFeb 24, 2023

THE LANCET ONCOLOGY: Experts warn of a European cancer epidemic in the next decade if weaknesses in cancer health systems and cancer research are not urgently addressed

A new report by the European Groundshot Commission highlights current and future challenges in cancer research across Europe. The authors estimate that approximately one million cancer diagnoses were missed during the COVID-19 pandemic, and the war in Ukraine poses a significant threat to clinical trials and workforce gaps.

SourceThe Lancet·JournalThe Lancet Oncology·TypeSystematic review·DateNov 15, 2022

New study shows two million life-years lost and $21 billion in lost earnings annually due to smoking associated cancer deaths

A new study by the American Cancer Society reports nearly 123,000 cancer deaths due to cigarette smoking in the US, resulting in over two million Person-Years of Lost Life (PYLL) and $21 billion in annual lost earnings. The losses were disproportionately higher in states with weaker tobacco control policies.

SourceAmerican Cancer Society·JournalInternational Journal of Cancer·DateAug 10, 2022

New study examining women’s breast density knowledge suggests opportunities for improvement

A new study suggests that while breast density knowledge may be increasing due to existing state laws, there is still room for improvement. The study found that most women with non-dense breasts did not correctly know their own density, and that lower education was associated with a lower chance of accurately knowing one's own density.

SourceDartmouth Health·JournalJournal of the American College of Radiology·TypeSurvey·DateApr 25, 2022

Half of all women experience false positive mammograms after 10 years of annual screening

A study published in JAMA Network Open found that half of all women will experience at least one false positive mammogram over a decade of annual breast cancer screening with 3D mammography. The risk of false positives is lower for women screened every other year, and non-dense breasts also show a lower false positive risk.

SourceUniversity of California - Davis Health·JournalJAMA Network Open·TypeData/statistical analysis·DateMar 25, 2022

Follow-up costs can add up if a free cancer screening shows a potential problem

New studies from Michigan Medicine researchers aim to remove financial barriers for patients who receive abnormal test results, enabling them to complete the diagnostic process. The findings suggest that removing cost barriers could save lives by increasing screening uptake, particularly among women and underserved populations.

SourceMichigan Medicine - University of Michigan·JournalJAMA Network Open·TypeData/statistical analysis·DateFeb 14, 2022

ESMO-WHO collaboration in Kazakhstan yields evidence-based approach for closing the gaps in access to high-quality cancer care

The ESMO-WHO collaboration developed an evidence-based methodology for evaluating national medication formularies, helping Kazakhstan update its list of essential cancer medicines and treatment protocols. The approach resulted in increased budget allocation to cancer care and improved access to high-quality treatments.

Children with chronic health conditions, and those with special education needs, should receive more help with online learning

Pediatric clinicians play a crucial role in ensuring access to critical resources for children with chronic medical conditions or special education needs. Clinicians should address school-related challenges and provide support to help these patients keep up academically with their peers.

SourceKennedy Krieger Institute·JournalJAMA Pediatrics·TypeCommentary/editorial·DateJan 4, 2022

New research in JNCCN raises concerns about clinical trial bias from undisclosed censoring

A recent study published in JNCCN found that 33 out of 81 studies lacked transparency on censoring, which can introduce bias and affect trial results. The researchers emphasize the need for improved transparency and reporting in clinical trials to ensure patients and clinicians make informed decisions.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateDec 15, 2021

Corporate influence linked to slow implementation of public health policies globally

A study found that only a third of public health policies had been fully implemented globally by 2020, with low-income countries and those with high corporate influence showing slow progress. The researchers suggest that corporate influence cancelled out the positive relationship between democracy and implementation, highlighting the n...

SourceKarolinska Institutet·JournalThe Lancet Global Health·TypeData/statistical analysis·DateOct 19, 2021

JNCCN: More people with cancer undergoing radiotherapy prefer telemedicine to in-person visits

A study published in JNCCN found that 45% of people with cancer prefer telemedicine over in-person visits, while general patient satisfaction scores are equally high. The research also revealed that patients preferred video conferencing over audio-only appointments and that telemedicine can reduce treatment-related costs.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·TypeSurvey·DateOct 19, 2021